A recent study sheds light on why children with relapsing Crohn’s disease continue to experience repeated episodes even after apparent recovery. This research opens up new possibilities for more effective treatments and potential cures.
Crohn’s disease is a severe inflammatory condition affecting the digestive tract, potentially leading to life-threatening complications. Common symptoms include abdominal pain, weakness, fatigue, and malnutrition due to poor nutrient absorption. While more prevalent in adults, this condition affects tens of thousands of children in the United States alone, disrupting their lives and childhood significantly. Children with Crohn’s may face growth impairments, delayed puberty, and the need for surgical removal of bowel sections.
The latest research at the University of Virginia highlights the reasons behind the recurrence of Crohn’s disease in children who seemingly recovered. Under the guidance of Dr. Chelsea Marie from UVA School of Medicine, undergraduate Rebecca Pierce discovered that children with relapsing Crohn’s exhibited a persistent disturbance in their gut microbiomes, even after successful inflammation control through treatment.
This discovery is crucial as it may help doctors develop more effective treatments or potentially find a cure for Crohn’s disease. Dr. Ning-Jiun “Ninj” Jan, a senior scientist in Dr. Marie’s lab, emphasized the significance of addressing the root cause rather than just managing symptoms to prevent relapses and improve patients’ long-term outcomes.
Crohn’s Disease in Children
While most Crohn’s disease research has focused on adult patients, this new study sheds light on the specific challenges faced by children with the condition. The researchers identified persistent inflammation and microbiome disruptions as key factors contributing to relapsing Crohn’s among children.
Comparing biopsy samples from children with Crohn’s in remission to those from a control group without the disease, the researchers found significant differences in bacterial composition and immune cell activity. Although existing treatments effectively alleviate symptoms, they may not fully address the underlying issues driving the disease, suggesting the need for more targeted therapies.
By restoring microbial balance through interventions like fecal transplants or tailored microbe therapies, doctors aim to prevent relapses and potentially cure Crohn’s disease in patients of all ages.
Publishing of Findings
Dr. Marie and her team have published their research findings on Crohn’s disease in the Nature journal Scientific Reports. The study, supported by the Bill and Melinda Gates Foundation, involved collaboration from various experts to advance knowledge in pediatric gastroenterology and infectious diseases.
To stay updated on the latest medical research news from the University of Virginia, readers can subscribe to the Making of Medicine blog.
